The Study That Changed Everything A Conversation with Teresa DeHaemerSenior Director of Business Strategy, Thalocan Research Innovations by Ginger Claremohr, Claremohr Writing Co. A single study changed the trajectory of Teresa DeHaemer’s career, but not in the way she might have expected. She was working in clinical psychology when she accepted a role supporting a…
DetailsMaking Understanding Possible A Conversation with Christopher GersonDirector of Production, Thalocan Research Innovations by Ginger Claremohr, Claremohr Writing Co. Chris Gerson doesn’t describe his work as making videos. He describes it as “making understanding possible.” “Storytelling is about helping people see clearly,” he explains. “In medicine, clarity isn’t just aesthetic. It shapes outcomes.” “The way…
DetailsKeeping the Focus on People A Conversation with Regan WannDirector of People and Project Engagement at Thalocan Research Innovations by Ginger Claremohr, Claremohr Writing Co. At Thalocan Research Innovations, Regan Wann keeps people at the center of highly technical systems, ensuring the human element doesn’t get lost. As Director of People and Project Engagement, she’s…
DetailsWhere Technology, Creativity, and Mission Converge Interview with Cyrus Mirakhor COO of Thalocan Research Innovations by Ginger Claremohr, Claremohr Writing Co. If you ask Cyrus Mirakhor what he does, he’ll be the first to admit it isn’t always easy to explain. As Chief Operating Officer of Thalocan Research Innovations, Cyrus works at the intersection of…
DetailsAll of us here at Thalocan Research Innovations applaud the work of The American Academy of Dermatology in designating November as National Healthy Skin Month. It is indeed an awareness month for all. At TRI we are proud to continue our goal to revolutionize the assessment of dermatological diseases with the latest technology, designed to enhance every…
DetailsAt SHSA 2025 in Nashville this past weekend, one of the primary topics discussed at our booth was the urgent needed for standardizing assessment for Hidradenitis Suppurativa. Being aware of the various ways that raters are CURRENTLY mapping lesions and how that process can be improved and standardized provided us with the roadmap we needed…
DetailsEric Zudak, CEO of Thalocan Research Innovations, discusses Thalocan’s role in helping to address unmet needs in the immunodermatology area. With many, if not most inflammatory skin diseases being more common in Skin of Color than in lighter pigmented skin – Thalocan is proud to provide cutting edge technology, training and tools for more accurate scientific…
DetailsWe are very excited to share our UPDATED comprehensive VASI training course! Authored by Dr. Iltefat Hamzavi, this enhanced training was designed by Thalocan Research Innovations to improve efficiency in clinical trial training management and support consistent severity assessment in #vitiligostudies. Please contact licensing@thalocan.com for details.
Looking forward to (nearly all of) our Thalocan Research Innovations Team meeting friends old and new at SHSA 2025 in Nashville, where we are a proud Bronze Sponsor! We have put a great deal of time and energy towards solutions to improve data quality, as well as patient experience and Investigator satisfaction. SHSA 2025 will…
DetailsDr. Amit Garg shares his experience with the unique challenges of disease assessment and measuring treatment response in Hidradenitis Suppurativa. At Thalocan Research Innovations we collaborate with experts like Dr. Garg and Dr. John Ingram, among others, to develop tools and applications that improve the experience for trialists and patients, as well as optimizing the…
Details
